智通财经APP讯,我武生物(300357.SZ)公告,公司获得国家药品监督管理局发出的《受理通知书》,由公司提交的“皮炎诊断贴剂02贴”药物临床试验申请已获得正式受理。相关适应症为:用于斑贴试验,辅助诊断与卡松、对苯二胺、甲醛致敏相关的变应性接触性皮炎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.